Literature DB >> 7891103

Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin.

T A Newcomer1, P A Rosenberg, E Aizenman.   

Abstract

2,4,5-Trihydroxyphenylalanine (TOPA) oxidizes in solution to form a quinone derivative that is a non-NMDA glutamatergic agonist and neurotoxin. DOPA can autoxidize in physiological solutions to form small amounts of both TOPA and TOPA quinone. We report here that this conversion can be dramatically enhanced by iron (II) alone, but more so by iron (II) in the presence of hydrogen peroxide. This conversion is of sufficient magnitude that the resulting product can elicit non-NMDA, glutamate receptor-mediated electrical responses in cultured cortical neurons isolated from rat. This finding suggests that TOPA quinone may play a role in pathological processes involving abnormal iron metabolism in catecholaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891103     DOI: 10.1046/j.1471-4159.1995.64041742.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking.

Authors:  L A Burzio; J H Waite
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 2.  Neurophysiology of the brain stem in Parkinson's disease.

Authors:  Cecilia Bove; R Alberto Travagli
Journal:  J Neurophysiol       Date:  2019-03-27       Impact factor: 2.714

3.  Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases.

Authors:  H M Schipper
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

4.  Taurine inhibition of metal-stimulated catecholamine oxidation.

Authors:  R Dawson; D Baker; B Eppler; E Tang; D Shih; H Hern; M Hu
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-ohda in rat.

Authors:  Dayane Pessoa de Araújo; Caren Nádia Soares De Sousa; Paulo Victor Pontes Araújo; Carlos Eduardo de Souza Menezes; Francisca Taciana Sousa Rodrigues; Sarah Souza Escudeiro; Nicole Brito Cortez Lima; Manoel Claúdio Azevedo Patrocínio; Lissiana Magna Vasconcelos Aguiar; Glauce Socorro de Barros Viana; Silvânia Maria Mendes Vasconcelos
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

6.  Levodopa: History and Therapeutic Applications.

Authors:  Sujith Ovallath; Bahiya Sulthana
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.